Scarica l'app Stockscreener
1.01
4.72%
-0.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.06
Aprire:
$1.06
Volume 24 ore:
100.02K
Relative Volume:
1.08
Capitalizzazione di mercato:
$61.61M
Reddito:
-
Utile/perdita netta:
$-25.65M
Rapporto P/E:
-2.0612
EPS:
-0.49
Flusso di cassa netto:
$-24.59M
1 W Prestazione:
-2.88%
1M Prestazione:
-7.34%
6M Prestazione:
-21.71%
1 anno Prestazione:
-40.59%
Intervallo 1D:
$1.01
$1.0612
Intervallo di 1 settimana:
$1.01
$1.08
Portata 52W:
$0.9054
$2.09
Vivani Medical Inc Stock (VANI) Company Profile
Nome
Vivani Medical Inc
Settore
Industria
Telefono
818-833-5000
Indirizzo
1350 S. LOOP ROAD, ALAMEDA
Confronta VANI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.012 | 61.61M | 0 | -25.65M | -24.59M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.78 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.51 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.13 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
228.81 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Vivani Medical Inc Borsa (VANI) Ultime notizie
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Vivani Medical (NASDAQ:VANI) Receives "Buy" Rating from HC Wainwright - MarketBeat
Head-To-Head Comparison: Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical’s (VANI) “Buy” Rating Reiterated at HC Wainwright - Defense World
Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - GlobeNewswire
Vivani Medical expands partnership with Okava for dog therapy By Investing.com - Investing.com South Africa
Vivani Medical And Okava Expand Collaboration To Develop Okv-119 For Dogs, Targeting Metabolic Health And Longevity - marketscreener.com
Vivani Medical expands partnership with Okava for dog therapy - Investing.com
Vivani Medical and Okava Expand Collaboration to Develop - GlobeNewswire
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity - Yahoo Finance
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs - Benzinga
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 44,400 Shares of Stock - MarketBeat
Vivani medical director Gregg Williams buys $21,233 in stock - Investing.com Australia
Vivani medical director Gregg Williams invests $21,233 in shares By Investing.com - Investing.com South Africa
Vivani medical director Gregg Williams buys $21,233 in stock By Investing.com - Investing.com Canada
Insider Buying: Vivani Medical, Inc. (NASDAQ:VANI) Director Buys 34,000 Shares of Stock - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical's director Gregg Williams acquires $205k in stock - Investing.com Australia
Vivani Medical’s director Gregg Williams acquires $205k in stock - Investing.com
Vivani Medical’s director Gregg Williams acquires $205k in stock By Investing.com - Investing.com South Africa
Vivani Medical's director Gregg Williams acquires $205k in stock By Investing.com - Investing.com India
Vivani Medical Director Gregg Williams Acquires Over 200K Shares - TradingView
Vivani Medical Announces Positive Preclinical Liver Fat Results with Miniature, Ultra Long-Acting GLP-1 Implant - MarketScreener
Vivani Medical (NASDAQ:VANI) Earns Buy Rating from HC Wainwright - Defense World
Vivani medical director Gregg Williams buys $24,959 in stock - Investing.com Australia
Vivani medical director Gregg Williams buys $24,959 in stock By Investing.com - Investing.com UK
Insider Purchases Worth US$5.02m See Losses As Vivani Medical Market Value Drops To US$60m - simplywall.st
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target By Investing.com - Investing.com Canada
H.C. Wainwright maintains Buy on Vivani Medical stock, $4 target - Investing.com India
Vivani Medical (NASDAQ:VANI) Posts Earnings Results, Misses Expectations By $0.01 EPS - MarketBeat
Vivani medical chief business officer purchases $4,100 in shares By Investing.com - Investing.com South Africa
Vivani medical chief business officer purchases $4,100 in shares - Investing.com India
Vivani Medical’s Strategic Positioning and Promising Developments Earn a Buy Rating Despite Price Target Reduction - TipRanks
Vivani Medical: Q4 Earnings Snapshot - CT Insider
Vivani Medical Reports 2024 Financial Results and Business Progress - TipRanks
Vivani Medical Inc. (VANI) reports earnings - Quartz
Vivani Medical Advances with Successful Milestones in 2024 - TipRanks
Vivani Medical, Inc. SEC 10-K Report - TradingView
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
HC Wainwright Reaffirms Buy Rating for Vivani Medical (NASDAQ:VANI) - MarketBeat
Vivani Medical announces $8.25M private placement equity financing - MSN
Vivani Medical Announces Promising Preclinical Weight Loss Data For Its Semaglutide Implant: Retail Sentiment - Asianet Newsable
Vivani Medical Inc Azioni (VANI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.77%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):